Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “NASH - Nonalcoholic Steatohepatitis With Liver Fibrosis”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableActive Not RecruitingNCT04383951
What this trial is testing

Safety and Efficacy of Ketogenic Diet for Promoting Weight Loss in Obese Individuals With Compensated NASH Cirrhosis

Who this might be right for
NASH - Nonalcoholic SteatohepatitisCirrhosis, Liver
Indiana University 40
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07631637
What this trial is testing

Study to Evaluate ALN-CIDEB in Adults With Fibrotic Metabolic Dysfunction-Associated Steatohepatitis (MASH)

Who this might be right for
Metabolic Dysfunction-Associated Steatohepatitis (MASH)
Regeneron Pharmaceuticals 150
Not applicableUnknownNCT04653311
What this trial is testing

Evaluation of an Endoscopic Sutured Gastroplasty in Patients With NonAlcoholic Steatohepatitis (NASH) and Fibrosis.

Who this might be right for
NASH - Nonalcoholic Steatohepatitis
Erasme University Hospital 100
Early research (Phase 1)Ended earlyNCT04766476
What this trial is testing

Evaluate the Safety, Tolerability, and Drug Levels of BMS-963272 in Participants With Nonalcoholic Fatty Liver Disease

Who this might be right for
Nonalcoholic Fatty Liver Disease
Bristol-Myers Squibb 9
Very early researchStudy completedNCT05737433
What this trial is testing

Single Dose ADME Study of [14C]-Rencofilstat in Healthy Male Subjects

Who this might be right for
NASH With Fibrosis
Hepion Pharmaceuticals, Inc. 6
Large-scale testing (Phase 3)Study completedNCT00244569
What this trial is testing

Development of a Breath Test for Monitoring Patients With Liver Disease

Who this might be right for
Fatty LiverCirrhosis
Virginia Commonwealth University 120
Early research (Phase 1)Study completedNCT04643795
What this trial is testing

Phase 1 Study to Evaluate the Pharmacokinetics, Safety, and Tolerability of Multiple Oral Doses of MGL-3196 in Subjects With Varying Degrees of Hepatic Impairment and Healthy Matched Control Subjects

Who this might be right for
Hepatic ImpairmentNASH - Nonalcoholic SteatohepatitisCirrhosis, Liver
Madrigal Pharmaceuticals, Inc. 87
Large-scale testing (Phase 3)Study completedNCT02395900
What this trial is testing

The Effects of Flaxseed Supplement on Biochemical Factors and Hepatic Fibrosis in Patients With Nonalcoholic Fatty Liver Disease

Who this might be right for
Non Alcoholic Steatohepatitis
National Nutrition and Food Technology Institute 50
Testing effectiveness (Phase 2)Looking for participantsNCT06588699
What this trial is testing

Digoxin In NASH (CODIN)

Who this might be right for
NASHNAFLDMASH - Metabolic Dysfunction-Associated Steatohepatitis+5 more
Yale University 144
Testing effectiveness (Phase 2)Study completedNCT00063232
What this trial is testing

Treating Nonalcoholic Steatohepatitis (NASH) With Metformin

Who this might be right for
Hepatitis
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) 28
Large-scale testing (Phase 3)Ended earlyNCT02704403
What this trial is testing

Phase 3 Study to Evaluate the Efficacy and Safety of Elafibranor Versus Placebo in Patients With Nonalcoholic Steatohepatitis (NASH)

Who this might be right for
Nonalcoholic Steatohepatitis (NASH) With Fibrosis
Genfit 2,157
Large-scale testing (Phase 3)Active Not RecruitingNCT04849728
What this trial is testing

Study Evaluating Efficacy and Safety of Lanifibranor Followed by an Active Treatment Extension in Adult Patients With (NASH) and Fibrosis Stages F2 and F3 ( NATiV3 )

Who this might be right for
NASH - Nonalcoholic Steatohepatitis
Inventiva Pharma 1,000
Testing effectiveness (Phase 2)Study completedNCT00885313
What this trial is testing

Effects of Docosahexaenoic Acid (DHA) on Children With Nonalcoholic Fatty Liver Disease (NAFLD)

Who this might be right for
Fatty LiverLiver FibrosisObesity+2 more
Bambino Gesù Hospital and Research Institute 60
Not applicableStudy completedNCT02044523
What this trial is testing

Noninvasive Staging of Liver Fibrosis: MR vs Ultrasound

Who this might be right for
Hepatitis CHepatitis BNonalcoholic Fatty Liver Disease (NAFLD)+1 more
Centre hospitalier de l'Université de Montréal (CHUM) 108
Testing effectiveness (Phase 2)Study completedNCT04173065
What this trial is testing

Assess the Efficacy and Safety of VK2809 for 52 Weeks in Subjects With Biopsy Proven NASH

Who this might be right for
NASH - Nonalcoholic Steatohepatitis
Viking Therapeutics, Inc. 248
Large-scale testing (Phase 3)Study completedNCT01934777
What this trial is testing

Efficacy and Tolerance of Treatment With DHA, Choline and Vitamin E in Children With Non-alcoholic Steatohepatitis

Who this might be right for
Fatty LiverLiver FibrosisObesity+2 more
Bambino Gesù Hospital and Research Institute 60
Testing effectiveness (Phase 2)UnknownNCT05402371
What this trial is testing

Evaluate the Efficacy and Safety of Rencofilstat in Subjects With NASH and Advanced Liver Fibrosis

Who this might be right for
Nonalcoholic Steatohepatitis (NASH)Fibrosis, LiverNAFLD
Hepion Pharmaceuticals, Inc. 120
Testing effectiveness (Phase 2)Ended earlyNCT01672879
What this trial is testing

Simtuzumab (SIM, GS-6624) in the Treatment of Cirrhosis Due to NASH

Who this might be right for
Liver Fibrosis Due to NASH
Gilead Sciences 259
Large-scale testing (Phase 3)Study completedNCT04197479
What this trial is testing

Evaluate Safety and Biomarkers of Resmetirom (MGL-3196) in Non Alcoholic Fatty Liver Disease Patients

Who this might be right for
Non-Alcoholic Fatty Liver Disease
Madrigal Pharmaceuticals, Inc. 1,343
Early research (Phase 1)Study completedNCT04634149
What this trial is testing

Evaluate the Drug Levels, Safety, and Tolerability of BMS-986036 in Participants With Normal Liver Function and Participants With Moderate and Severe Liver Impairment

Who this might be right for
Moderate Liver ImpairmentSevere Liver Impairment
Bristol-Myers Squibb 16
Next Page